Should the patient discontinue bupropion (Wellbutrin) due to new onset bruxism?

Do Not Discontinue Wellbutrin for New-Onset Bruxism

Bruxism (teeth grinding) is a recognized but uncommon side effect of bupropion that does not warrant automatic discontinuation—instead, manage the bruxism symptomatically while continuing the antidepressant if it is providing therapeutic benefit for the underlying condition.

Clinical Reasoning

The available evidence does not support discontinuing bupropion solely for bruxism, particularly when the medication is effectively treating depression, ADHD, or supporting smoking cessation. The guidelines for bupropion use 1, 2 emphasize that side effects should be weighed against the substantial benefits of treatment, and discontinuation is typically reserved for serious adverse events like seizures, severe neuropsychiatric symptoms, or intolerable reactions—not movement-related side effects like bruxism.

Key Evidence Points:

• Bruxism is documented but rare: While case reports 3, 4 confirm that bupropion can cause or exacerbate bruxism, this is not listed among the common reasons for drug discontinuation in clinical trials 2, where the most frequent causes were tremor, rash, headache, and urticaria (7-12% discontinuation rates).

• Risk-benefit analysis favors continuation: The FDA label 5 and clinical guidelines 1 emphasize that bupropion's benefits for treating depression and supporting smoking cessation substantially outweigh risks of manageable side effects. Discontinuation is recommended primarily for seizures, severe psychiatric symptoms, or contraindicated conditions (brain metastases, eating disorders, MAO inhibitor use).

• Recent research context: A 2024 study 6 found that SSRIs/SNRIs increased sleep bruxism by week 4 of treatment, but notably, bupropion was not included in this analysis. A 2020 case report 3 actually described a patient on bupropion who developed bruxism that resolved with pregabalin—the bruxism was attributed to anxiety, not the bupropion itself.

Management Algorithm

Step 1: Confirm the Diagnosis

• Verify bruxism is actually new-onset (not pre-existing and now noticed)
• Assess severity: jaw pain, tooth damage, headaches, sleep disruption
• Rule out other causes: anxiety worsening, caffeine/stimulant use, sleep disorders

Step 2: Assess Therapeutic Response to Bupropion

• Is the patient experiencing benefit from bupropion for their primary indication (depression, ADHD, smoking cessation)?
• How long have they been on treatment? (Premature discontinuation may prevent achieving full therapeutic effect)
• Are there contraindications that were missed initially?

Step 3: Manage Bruxism Without Stopping Bupropion

First-line interventions:

• Prescribe a dental night guard (occlusal splint) for sleep bruxism
• Address contributing factors: reduce caffeine, optimize sleep hygiene, manage stress
• Consider adding buspirone 5-10 mg twice daily (has evidence for reducing SSRI-induced bruxism, may help here)
• Trial of gabapentin 300-900 mg or pregabalin 75-375 mg if bruxism is severe 3

Monitor for 2-4 weeks:

• If bruxism improves with conservative measures → continue bupropion
• If bruxism persists but is tolerable and bupropion is effective → continue both treatments
• If bruxism causes significant dental damage or pain despite interventions → proceed to Step 4

Step 4: Consider Medication Adjustment (Only if Step 3 Fails)

Option A - Dose reduction:

• Reduce bupropion from 300 mg to 150 mg daily
• Monitor for both bruxism improvement AND maintenance of therapeutic effect
• Guidelines 1 note that dose adjustments may be considered as clinically indicated

Option B - Switch formulations:

• One case report 7 showed tolerance of bupropion SR after reaction to XL formulation
• Consider switching between IR/SR/XL if patient had good response but intolerable side effect

Option C - Switch antidepressants (last resort):

• Only if bruxism is severe, unmanageable, AND other options exhausted
• Switch to alternative antidepressant based on indication 8
• Note: SSRIs/SNRIs may also cause bruxism 6, so this may not solve the problem

Critical Caveats

Common pitfall: Prematurely discontinuing an effective antidepressant for a manageable side effect, leading to depression relapse. The guidelines 1 emphasize that "in most circumstances, the side effects related to preferred smoking cessation medications are minimal and are considered an acceptable risk compared to smoking" (or untreated depression).

Important distinction: If the patient develops severe neuropsychiatric symptoms (agitation, suicidal ideation, severe mood changes) or seizures, discontinue immediately 1, 5. Bruxism does not fall into this category.

Timing consideration: The 2024 study 6 found bruxism typically emerges by week 4 of antidepressant treatment. If your patient just started bupropion, the bruxism may be coincidental or related to the underlying psychiatric condition rather than the medication.